- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05408390
Effects of Energy and Physical Density Manipulation on Appetite
August 21, 2023 updated by: United States Army Research Institute of Environmental Medicine
As individuals tend to eat a constant weight or volume of food, manipulating physical and energy densities generally results in changes in energy intake without affecting subjective appetite sensations.
However, relatively few studies have directly studied the interaction between physical and energy density manipulation.
This study will determine the effects of foods that systematically vary in physical and energy density on ad libitum energy intake and subjective appetite ratings.
Secondary outcomes will include gastrointestinal discomfort, fatigue and acceptability.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A historical challenge for military personnel operating in austere, remote environments is the ability to pack and carry enough food to sustain their operational and nutritional needs.
To address this challenge and meet Army modernization requirements, US Army ration developers are developing a new ration to provide a lightweight, low volume, energy dense daily combat assault ration.
The ration will use novel food processing techniques that remove air and water to reduce volume and increase physical density (g/cc) and will provide a high relative fat content to increase energy density (kcal/g or kcal/cc).
As individuals tend to eat a constant weight or volume of food, manipulating physical and energy densities generally results in changes in energy intake without affecting subjective appetite sensations.
However, relatively few studies have studied the independent effects on appetite and energy intake of increasing physical and energy densities of foods to the extent being targeted by the new ration, and none has directly studied the interaction between physical and energy density manipulation.
This study will address that gap by determining the effects of foods that systematically vary in physical and energy density on ad libitum energy intake and subjective appetite ratings.
Secondary outcomes will include gastrointestinal discomfort, fatigue and acceptability.
Using a randomized, crossover design consisting of four separate phases, 20 participants will be provided with a standard base diet and experimental foods in which physical and energy density are systematically varied using different levels of mechanical compression and aeration, and different proportions of fat and carbohydrate, respectively.
Consumption of the experimental foods at each of the physical and energy density combinations will be compulsory for 1 day while intake of the standard diet will be ad libitum.
Total energy and macronutrient intake will be measured by collecting uneaten food items.
Additionally, perceived appetite, gastrointestinal symptoms, fatigue and acceptability of the experimental food products will be measured by questionnaire.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Natick, Massachusetts, United States, 01760
- US Army Research Institute of Environmental Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 35 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Body mass index (BMI) ≤ 30.0 kg/m2
- Willing to abstain from alcohol for 24 hours prior to and during days 1-2 of each study phase.
- Willing to abstain from strenuous exercise for 24 hours prior to and during days 1-2 of each study phase.
- Willing to abstain from a vegetarian/vegan diet or other highly restrictive diet (e.g., ketogenic diet, very high protein diet, Paleo diet) for two weeks prior to and throughout the study.
- Willing to maintain body weight throughout study.
- Willing to maintain usual diet (if not a restrictive diet), physical activity (aside from strenuous exercise limitation for 24 hours prior to and days 1-2 of each study phase) and nicotine use throughout study.
- Willing to abstain from dietary supplements (e.g., metabolism boosters, appetite suppressants, weight loss aids) impacting appetite or metabolism (as determined by study PI) throughout the study.
- Eats 3 meals per day at least 5 days/wk
Exclusion Criteria:
- Pregnant or lactating.
- Taking prescription medications, other than a contraceptive, known to affect appetite, digestion and/or metabolism (e.g., anti-diabetic agents) (unless approved by study PI)
- Any chronic medical condition that limits food intake or alters metabolism, appetite or digestive physiology (e.g., gastric bypass, gastrointestinal disease, dysphagia, diabetes).
- Allergies and intolerances (e.g. gluten, dairy, nuts), unwillingness or inability to eat provided foods and beverages.
- Score of ≥13 on the restraint scale or ≥9 on the disinhibition scale of the Eating Inventory
- Weight gain or loss of >5 lbs in the 2 weeks prior to study participation.
- Not willing or unable to adhere to all study procedures and restrictions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Low physical and energy density
|
Low physical density (LPD) + low energy density (LED) foods.
Participants receive breakfast, lunch and snack items engineered to have LPD and LED.
|
|
Experimental: High physical and low energy density
|
High physical density (HPD) + low energy density (LED) foods.
Participants receive breakfast, lunch and snack items engineered to have HPD and LED.
|
|
Experimental: Low physical and high energy density
|
Low physical density (LPD) + high energy density (HED) foods.
Participants receive breakfast, lunch and snack items engineered to have LPD and HED.
|
|
Experimental: High physical and energy density
|
High physical density (HPD) + high energy density (HED) foods.
Participants receive breakfast, lunch and snack items engineered to have HPD and HED.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total energy intake
Time Frame: Day 1 of each study arm.
|
Total energy intake from provided diet measured by weighing provided and uneaten foods.
|
Day 1 of each study arm.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Carbohydrate intake
Time Frame: Days 1 and 2 of each study arm
|
Total carbohydrate intake from provided and self-selected diet measured by weighing provided and uneaten foods, and food records.
|
Days 1 and 2 of each study arm
|
|
Protein intake
Time Frame: Days 1 and 2 of each study arm
|
Total protein intake from provided and self-selected diet measured by weighing provided and uneaten foods, and food records.
|
Days 1 and 2 of each study arm
|
|
Fat intake
Time Frame: Days 1 and 2 of each study arm
|
Total fat intake from provided and self-selected diet measured by weighing provided and uneaten foods, and food records.
|
Days 1 and 2 of each study arm
|
|
Self reported energy intake
Time Frame: Day 2 of each study arm
|
Energy intake from self-selected diet measured by food records.
|
Day 2 of each study arm
|
|
Appetite
Time Frame: Immediately before, immediately after and 15 min after breakfast, lunch and afternoon snack on day 1 of each study arm
|
Hunger, fullness, desire to eat and prospective consumption measured by 100mm visual analog scale.
Range is 0 to 100, with higher scores indicating greater hunger/fullness/desire/prospective consumption.
|
Immediately before, immediately after and 15 min after breakfast, lunch and afternoon snack on day 1 of each study arm
|
|
Fatigue
Time Frame: Immediately before, immediately after and 15 min after breakfast, lunch and afternoon snack on day 1 of each study arm
|
Level of fatigue measured by integer scale ranging from 0 (not tired) to 10 (total exhaustion)
|
Immediately before, immediately after and 15 min after breakfast, lunch and afternoon snack on day 1 of each study arm
|
|
Gastrointestinal symptoms
Time Frame: Immediately before, immediately after and 15 min after breakfast, lunch and afternoon snack on day 1 of each study arm
|
Heartburn, bloating, abdominal pain, urge to vomit, nausea, gas, urge to defecate, overall gastrointestinal discomfort measured by 100mm visual analog scale.
Range 0 (none) to 100 (extremely severe).
|
Immediately before, immediately after and 15 min after breakfast, lunch and afternoon snack on day 1 of each study arm
|
|
Acceptability
Time Frame: At breakfast, lunch and afternoon snack on day 1 of each study arm
|
Appearance, odor, flavor, texture, and overall acceptability of experimental foods rated on scale ranging from 1 (dislike extremely) to 9 (like extremely).
|
At breakfast, lunch and afternoon snack on day 1 of each study arm
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: J. Philip Karl, US Army Research Institute of Environmental Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 5, 2022
Primary Completion (Actual)
May 4, 2023
Study Completion (Actual)
May 4, 2023
Study Registration Dates
First Submitted
May 24, 2022
First Submitted That Met QC Criteria
June 1, 2022
First Posted (Actual)
June 7, 2022
Study Record Updates
Last Update Posted (Actual)
August 24, 2023
Last Update Submitted That Met QC Criteria
August 21, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 22-03HC
- M-10975 (Other Identifier: US Army Medical Research and Development Command IRB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.